Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03243513 · ClinicalTrials.gov registry record
Abo Follow-up Study
A clinical trial, sponsored by University of New Mexico.
- Terminated
- Registry status
- 1,600
- Enrollment target
NCT03243513: Clinical Trial study, sponsored by University of New Mexico.
NCT03243513 is a clinical trial that was terminated before completion, run by University of New Mexico. The registered enrollment target is 1,600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03243513 was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- 1,600 participants
- Enrollment target
Study Summary
The aim of the project is to identify an efficient and effective policy or procedure for identifying complications from surgical abortions through follow-up phone calls.
Primary Outcome
Key questions include, what is our complication-detection rate from these phone calls? How many patients are contacted? How many attempts are made and how much effort is expended by staff in routine follow-up practices?
Interventions
- OTHER Retrospective Chart Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2017-08-04 |
| Est. Completion | 2020-02-28 |
Why NCT03243513 stopped before completion
NCT03243513 is an observational study that tracks outcomes without assigning an intervention. Its 1,600 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Retrospective Chart Review is the first listed.
NCT03243513 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03243513 about?
NCT03243513 is a clinical study titled "Abo Follow-up Study". The aim of the project is to identify an efficient and effective policy or procedure for identifying complications from surgical abortions through follow-up phone calls.
What is the current status of trial NCT03243513?
This trial is currently terminated. The enrollment target is 1,600 participants. The study started on 2017-08-04. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT03243513?
The interventions under investigation include: Retrospective Chart Review (OTHER).
Who is sponsoring clinical trial NCT03243513?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI